Vivos Therapeutics VVOS

NASDAQ VVOS
$0.13 +0.00 (+2.90%)
At close: Oct 19, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) stock price is $0.13, up 2.90% on the day, as of Oct 19, 2026. It has a market cap of $2.37Mn, and is classified in the Dental industry (Healthcare sector).

Key Stats
Market Cap2.37 Mn
P/E-0.09
P/S0.11
Div. Yield0.00
Total Debt (Qtr)8.14 Mn
Revenue Growth (1y) (Qtr)34.90
Add ratio to table…

About

Vivos Therapeutics Inc is a revenue stage medical technology and healthcare services company that offers a comprehensive suite of proprietary oral appliances and therapeutic treatments known as the Vivos Method. The Vivos Method non surgically treats maxillofacial and developmental abnormalities of the mouth and jaws that are linked to breathing and sleep disorders such as obstructive sleep apnea and snoring in adults. The company also provides diagnostic and treatment…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue is derived from medical technology (FDA-cleared oral appliances) and healthcare services (diagnostic and treatment services at Sleep and Airway Medicine Centers). It specifically targets the treatment of obstructive sleep apnea and snoring, fitting squarely within the Medical Devices and Healthcare Services industries. Industries: Dental Dental Primary Vivos Therapeutics sells proprietary oral appliances (such as Versa, Vida, and Tooth Positioners) and operates dental service organizations to treat maxillofacial abnormalities. Its core product is a non-surgical dental-based therapy for obstructive sleep apnea and snoring. Healthcare Services Healthcare Services Secondary The company operates Sleep and Airway Medicine Centers that provide diagnostic and treatment services, including sleep testing, and manages sleep medical practices via management services organizations. Diagnostic Equipment Diagnostic Equipment Secondary Vivos generates revenue from leasing SleepImage home sleep test recorders, which are diagnostic equipment used to identify sleep disorders. Classified using BQ-MICS CIK: 0001716166

Product and Service Breakdown of Revenue (2025)

History
Peer percentiles

How Vivos Therapeutics ranks

Ranked against the 248 companies in Medical Devices and Diagnostics58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −0.10xMedian 28.9x 5th
  • P/FCFNegative free cash flow −0.08xMedian 26.0x 3rd
  • P/Operating cash flowNegative operating cash flow −0.12xMedian 20.1x 3rd
  • P/S 0.10xMedian 3.07x 98th
  • P/BNegative shareholder equity −0.51xMedian 2.40x Not meaningful —
  • P/Tangible bookNegative tangible equity −0.27xMedian 3.05x Not meaningful —
  • EV/EBITDANegative EBITDA −0.40xMedian 18.0x 6th
  • EV/EBITNegative EBIT −0.37xMedian 27.8x 7th
  • EV/Revenue 0.40xMedian 3.25x 95th
  • EV/FCFNegative free cash flow −0.35xMedian 26.6x 5th
  • EV/Operating cash flowNegative operating cash flow −0.49xMedian 21.9x 8th
  • PEG (3Y EPS CAGR)Negative earnings 0.00Median 0.86 Not meaningful —
Peer group

Peer Comparison

Companies in the Dental
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 251.93 Bn36.165.4442.55 Bn
2 ABT Abbott Laboratories 181.29 Bn33.423.8932.61 Bn
3 DHR Danaher Corp /De/ 158.18 Bn39.506.3026.56 Bn
4 ISRG Intuitive Surgical Inc 153.47 Bn48.8913.91-
5 MDT Medtronic plc 118.97 Bn22.743.1728.15 Bn
6 SYK Stryker Corp 114.72 Bn30.774.4414.94 Bn
7 BSX Boston Scientific Corp 66.18 Bn18.013.1512.62 Bn
8 VVOS Vivos Therapeutics, Inc. 0.00 Bn-0.090.110.01 Bn